NCT06416618

Brief Summary

The goal of this clinical trial is to study whether surgery results in better functional outcomes than non-surgical treatment among patients aged 50-65 with a displaced proximal humerus fracture. The main questions it aims to answer are:

  • Does osteosynthesis result in better patient-reported functional outcomes compared to non-surgical treatment at 12 months follow-up? Aim is also to characterize the patient group aged 50-65 regarding fracture morphology, osteoporosis, and clinical frailty scale. The study compare operation with either plate or nail fixation to non-surgical treatment. Participants will:
  • Receive either surgical treatment or non-surgical treatment.
  • At 6 months, 1 year, and 2 years, the patient will answer two short questionnaires (Oxford Shoulder Score and Eq-5D-3L). The primary outcome will be Oxford Shoulder Score at 12 months. The secondary outcome will be OSS at 6 and 24 months and EQ-5D-3L score measured at the same time-points. Adverse events and conversion to surgery will be registered. OSS and EQ-5D-3L will be completed just before the 6 months visit.

Trial Health

80
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
32mo left

Started May 2024

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress43%
May 2024Dec 2028

First Submitted

Initial submission to the registry

May 8, 2024

Completed
7 days until next milestone

Study Start

First participant enrolled

May 15, 2024

Completed
1 day until next milestone

First Posted

Study publicly available on registry

May 16, 2024

Completed
3.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2028

Last Updated

September 18, 2025

Status Verified

September 1, 2025

Enrollment Period

3.6 years

First QC Date

May 8, 2024

Last Update Submit

September 11, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Oxford Shoulder Score 12 months

    Oxford Shoulder Score is a patient-reported shoulder-specific outcome measure. It is a patient-administrated questionnaire to assess shoulder function. It consists of 12 questions on a 5-point Likert scale (both pain- and function-related), each offering five ordinal response options. The cumulative score ranges between 0 and 48, being 0 (worst) to 48 (best: no pain or no functional limitation).

    12 months

Secondary Outcomes (4)

  • Oxford Shoulder Score

    6 and 24 months

  • EQ-5D-3L

    6, 12 and 24 months

  • Conversion to surgery after inclusion, or additional surgery

    24 months

  • Adverse events.

    24 months

Study Arms (2)

Non-surgical treatment

EXPERIMENTAL

Patients in the non-surgical group will be offered an optional sling for comfort for an additional 1-2 weeks at their first visit,

Procedure: Non surgical

Procedure: Surgical treatment

ACTIVE COMPARATOR

The surgical group will receive osteosynthesis with a locking plate or an intramedullary locking nail, according to the surgeon's choice

Procedure: Surgical

Interventions

SurgicalPROCEDURE

Surgical group: After osteosynthesis, they will be provided with a sling and swathe immediately after the surgery. From the first postoperative day, only the sling will be used. Two weeks postoperatively, patients will undergo clinical and radiological follow-up in the outpatient clinic. They will be referred to post-operative rehabilitation in the municipalities. At 12 weeks postoperatively, patients will have another clinical and radiological follow-up. This is the current standard care for surgical treatment with a plate or intramedullary nail.

Procedure: Surgical treatment
Non surgicalPROCEDURE

Non-surgical group: Patients in the non-surgical group will be offered an optional sling for comfort for an additional 1-2 weeks at their first visit, 10-14 days post-injury. Patients will be referred to rehabilitation in the municipalities. At week 6 post-injury, all patients will undergo clinical and radiological follow-up. This represents the current standard care for non-surgical treatment of displaced PHF at the departments.

Non-surgical treatment

Eligibility Criteria

Age50 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged between 50 and 65 years with a displaced PHF assessed to be constructible by the treating surgeon after a low-energy trauma will be considered for eligibility.
  • Patients should be cognitively capable of answering the follow-up questionnaires.

You may not qualify if:

  • The patient does not understand written and spoken native language (Danish or Finnish/Swedish)
  • Inability to give informed consent
  • Fractures assessed to be unreconstructedly by the treating surgeon
  • Isolated tuberosity fracture, fracture dislocations, open fractures, and fractures with involvement of the articular surface
  • Less than 25% contact between head fragment and metaphysis/diaphysis measured at two perpendicular radiographs at two weeks.
  • Pathological fractures or previous fractures in the same proximal humerus
  • Concomitant fractures, which could influence the outcome
  • Paralysis in upper extremity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre for Evidence-Based Orthopaedics, Zealand University Hospital

Køge, Region Sjælland, 4600, Denmark

RECRUITING

Tampere University Hospital

Tampere, 33520, Finland

NOT YET RECRUITING

Related Publications (5)

  • Handoll HH, Elliott J, Thillemann TM, Aluko P, Brorson S. Interventions for treating proximal humeral fractures in adults. Cochrane Database Syst Rev. 2022 Jun 21;6(6):CD000434. doi: 10.1002/14651858.CD000434.pub5.

    PMID: 35727196BACKGROUND
  • Alispahic N, Brorson S, Bahrs C, Joeris A, Steinitz A, Audige L. Complications after surgical management of proximal humeral fractures: a systematic review of event terms and definitions. BMC Musculoskelet Disord. 2020 May 26;21(1):327. doi: 10.1186/s12891-020-03353-8.

    PMID: 32456631BACKGROUND
  • Brorson S, Alispahic N, Bahrs C, Joeris A, Steinitz A, Audige L. Complications after non-surgical management of proximal humeral fractures: a systematic review of terms and definitions. BMC Musculoskelet Disord. 2019 Feb 23;20(1):91. doi: 10.1186/s12891-019-2459-6.

    PMID: 30797232BACKGROUND
  • Audige L, Brorson S, Durchholz H, Lambert S, Moro F, Joeris A. Core set of unfavorable events of proximal humerus fracture treatment defined by an international Delphi consensus process. BMC Musculoskelet Disord. 2021 Nov 30;22(1):1002. doi: 10.1186/s12891-021-04887-1.

    PMID: 34847888BACKGROUND
  • Houkjaer L, Launonen AP, Sumrein BO, Karna L, Issa Z, Holtz KB, Brorson S. Surgical versus non-surgical treatment of proximal humerus fracture in patients aged 50-65 years: young shoulder CARE (displaCed proximAl humeRus fracturE) trial-a pragmatic randomized controlled trial study protocol. Trials. 2025 Dec 29;26(1):588. doi: 10.1186/s13063-025-09283-x.

Related Links

MeSH Terms

Conditions

Shoulder Fractures

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Fractures, BoneWounds and InjuriesShoulder Injuries

Study Officials

  • Line Løjbert Houkjær, M.D.

    Center for evidensbaseret ortopædkirurgi, Sjællands Universitets Hospital, Køge.

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Line Løjbert Houkjær, M.D., ph.d.-student

CONTACT

Stig Brorson, Prof.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
The primary investigator will conduct the blinded statistical analysis through data anonymization and will be supervised by a biostatistician. After the blinded statistical analysis has been completed, two abstracts will be written based on the pre-blinding analysis results before the blinding is revealed.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study is a two-center, parallel-group, randomized, superiority trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator, M.D.

Study Record Dates

First Submitted

May 8, 2024

First Posted

May 16, 2024

Study Start

May 15, 2024

Primary Completion (Estimated)

December 31, 2027

Study Completion (Estimated)

December 31, 2028

Last Updated

September 18, 2025

Record last verified: 2025-09

Data Sharing

IPD Sharing
Will not share

No individual participant data (IPD) available to other researchers.

Locations